DUBLIN, July 22, 2022 /PRNewswire/ -- The "Immunoassay Market: Strategies and Trends, Forecasts by Application, Technology, Product, User and by Country, with Multiplex and Point of Care Market Analysis, Executive Guides, Customized Forecasting and Analysis" report has been added to ResearchAndMarkets.com's offering.

Research_and_Markets_Logo

The workhorse of the diagnostic industry is finding new legs. The pandemic has created a new demand for rapid easily available diagnostics. Immunoassay is stepping up.

Advances in genetic knowledge are creating new markets for immunoassay. Rapid diagnostics, point of care, biomarkers and consumer markets are all areas of expansion while traditional immunoassay maintains a strong position in the growing market for clinical diagnostics.

The report profiles 58 companies, large and small, working in this area. This research makes you the expert in your organization.

Key Topics Covered:

1 Market Guides1.1 Immunoassay Market - Strategic Situation Analysis & COVID Impact1.2 Guide for Executives, Marketing, Sales and Business Development Staff1.3 Guide for Management Consultants and Investment Advisors

2 Introduction and Market Definition2.1 Immunoassay Markets Definition In This Report2.1.1 Enzyme Based2.1.2 Immunofluorescence2.1.3 Chemiluminescence2.1.4 DNA/NAT2.1.5 RIA & Other2.1.6 Reagents/Kits, Analyzers, Software & Services2.1.7 Infectious Disease2.1.8 Auto-Immune2.1.9 Endocrinology2.1.10 Oncology2.1.11 Cardiology2.1.12 Other Specialty2.2 Market Definition2.2.1 Market Sizes2.2.2 Currency2.2.3 Years2.3 Methodology2.3.1 Authors2.3.2 Sources2.4 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic2.4.1 Global Healthcare Spending2.4.2 Spending on Diagnostics2.4.3 Important Role of Insurance for Diagnostics

3 Industry Overview3.1 Industry Participants3.1.1 IVD Supplier3.1.2 Independent lab specialized/esoteric3.1.3 Independent lab national/regional3.1.4 Independent lab analytical3.1.5 Public National/regional lab3.1.6 Hospital lab3.1.7 Physician lab3.1.8 Audit body3.2 The Clinical Laboratory Market Segments3.2.1 Traditional Market Segmentation3.2.2 Laboratory Focus and Segmentation3.2.3 Hospital Testing Share3.2.4 Economies of Scale3.2.5 Hospital vs. Central Lab3.2.6 Physician Office Lab's3.2.7 Physician's and POCT3.3 Immunoassay -Markets and Discussion3.3.1 Instruments - Genetics changes the picture3.3.1.1 RIA - A Technology Shows its Age3.3.1.2 Immunoassay vs. PCR vs. Sequencing - A See-Saw Battle3.3.1.3 The Smart Shrinking Instrument - Serious Implications3.3.1.4 Research Funding and Capital Expense - Instrument Pooling3.3.1.5 Multiplex vs. POC - A Tradeoff Analysis3.3.2 Reagents and Kits - Genetics changes the picture3.3.2.1 Bigger Test Menus a Boon for Kit Market3.3.2.2 Physician Office Labs - A New Frontier3.3.3 Rapid and POCT to Threaten Instrument Markets3.3.4 OTC and DTC - Huge Market Potential3.3.5 Economies of Scale. Going Away?3.3.6 Lower Barriers to Entry for Instruments/Analyzers3.3.7 Miniaturization and Technology Drive Acquisition

Story continues

4 Market Trends4.1 Factors Driving Growth4.1.1 Diagnostic Factors4.1.2 Changing Technologies Spur Early Instrument Retirement4.1.3 Consumer Channels Open Wider4.1.4 Immunity Technology Comes of Age4.2 Factors Limiting Growth4.2.1 Increased Competition Lowers Price4.2.2 Threat from PCR Based Instruments4.2.3 Lower Barriers to Entry4.2.4 Wellness has a downside4.3 Immunoassay Instrumentation4.3.1 Instrumentation Tenacity4.3.2 Declining Cost of Instruments Changes Industry Structure4.3.3 Listing of Instrument Specifications4.3.4 Immunoassay - CRISPR Diagnostics

5 Immunoassay Recent Developments5.1 Recent Developments - Importance and How to Use This Section5.1.1 Importance of These Developments5.1.2 How to Use This Section5.2 FDA Grants EUA to Xtrava Health COVID Point-of-Care Antigen Test5.3 Alamar Biosciences Raises $80M for Immuno-Sandwich Assay Platform5.4 FDA grants breakthrough device to multiplex immunoassay5.5 Quidel, Beckman Settle Cardiac Immunoassay Dispute5.6 BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership5.7 BioMerieux Gets CE Mark for Three Dengue Immunoassays5.8 COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing5.9 Roche Diagnostics Expanding Testing Portfolio in 20215.10 PerkinElmer Long-Term Outlook5.11 Quidel Updates Outlook for C19 Testing5.12 Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza5.13 Becton Dickinson and NAT Diagnostics Acquisition5.14 New test diagnoses Lyme disease within 15 minutes5.15 Multiplexed Immunoassay System Differentiates Malaria Species5.16 ERBA Mannheim Unveils Next-Generation Nexus unit5.17 Uman Diagnostics And Bio-Techne Announce Agreement For Neurofilament Light Assay5.18 Software reduces variability in ELISA biomarker tests5.19 Arrayit Corporation Allergy Testing Network Doubles

6 Profiles of Key Companies6.1 Abbott Diagnostics6.2 Abcam6.3 Arlington Scientific6.4 Arrayit Corporation6.5 Autobio Diagnostics6.6 Awareness Technology6.7 Beckman Coulter Diagnostics6.8 Becton, Dickinson and Company6.9 Biocartis6.10 Biomatik6.11 bioMerieux Diagnostics6.12 Bioneer Corporation6.13 Bio-Rad Laboratories, Inc.6.14 BioTek Instruments6.15 Boditech Med, Inc6.16 Boster Biological Technology6.17 Diamedix (Erba Diagnostics)6.18 Diasorin S.p.A.6.19 Dynex Technologies6.20 Enzo Biochem6.21 Eurofins Scientific6.22 FUJIFILM Wako Diagnostics6.23 Fujirebio6.24 Gold Standard Diagnostics6.25 Grifols6.26 Hycor Biomedical6.27 Immunodiagnostic Systems (IDS)6.28 Immunodiagnostik AG6.29 Inova Diagnostics6.30 JR Biomedical6.31 Luminex Corp6.32 Maxim Biomedical6.33 Mbio Diagnostics6.34 Meso Scale Discovery6.35 Millipore Sigma6.36 Mindray6.37 Molecular Devices6.38 MP Biomedical6.39 MyCartis6.40 Operon6.41 Ortho Clinical Diagnostics6.42 Perkin Elmer6.43 Qiagen Gmbh6.44 Quidel6.45 R&D Systems6.46 Randox Toxicology6.47 Roche Molecular Diagnostics6.48 SD Biosensor6.49 Serametrix6.50 Siemens Healthineers6.51 Sysmex6.52 Tecan6.53 Thermo Fisher Scientific Inc.6.54 TOSOH Bioscience6.55 Veredus Laboratories6.56 Vircell6.57 YD Diagnostics6.58 Zhejiang Orient Gene Biotech

7 The Global Market7.1 Global Market by Country7.2 Global Market by Application7.3 Global Market by Technology7.4 Global Market by Product7.5 Global Market by User

8 Global Market by Application8.1 Endocrinology Applications8.2 Immune Applications8.3 Oncology Applications8.4 Infectious Disease Applications8.5 Cardiology Applications8.6 Other Applications

9 Immunoassay by Technology9.1 Enzyme9.2 Fluorescence9.3 Chemiluminescence9.4 Nucleic Acid9.5 Rapid/POC9.6 Other Technology

10 Immunoassay by Product10.1 Instrument10.2 Reagents10.3 Services

11 Immunoassay by User11.1 Hospital11.2 Outpatient Lab11.3 POC/Other

12 Vision of the Future of Immunoassay

13 Appendices13.1 United States Medicare System: 2021 laboratory Fees Schedule

For more information about this report visit https://www.researchandmarkets.com/r/wnx0xr

Media Contact:

Research and MarketsLaura Wood, Senior Managerpress@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716

Cision

View original content:https://www.prnewswire.com/news-releases/global-immunoassay-market-strategies-trends-forecasts-2022-2027-the-genetic-blizzard-and-the-move-to-point-of-care-drive-dramatic-change-for-traditional-immunoassay-technology-301591725.html

SOURCE Research and Markets

View post:
Global Immunoassay Market Strategies, Trends, Forecasts 2022-2027: The Genetic Blizzard and the Move to Point of Care Drive Dramatic Change for...